Benzodiazepine absetzen im Alter

Wann und, wenn ja, wie?

Bidragets oversatte titel: Discontinuation of benzodiazepines in old age : When and if so, how?

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

Although viewed critically in geriatrics, benzodiazepine use is still common among old people. Before reducing the dosage the following questions must be considered: 1. Are there indications for benzodiazepine treatment and will discontinuation cause relevant rebound symptoms of the initial disorder treated? 2. To what extent do the patient and other key persons consider discontinuation to be reasonable and will they support discontinuation? 3. Is the target complete withdrawal, a dose reduction or shift to another benzodiazepine drug which is more suitable in old age for pharmacokinetic reasons? This article provides assistance in answering these questions and some guidelines for the practical management of discontinuation. It is mandatory 1) to periodically address the problem of long-term benzodiazepine use when counseling the patient and key persons and 2) to be aware that several intermediate steps exist between continuation and complete discontinuation, which may be considered successful treatment.
OriginalsprogTysk
TidsskriftZeitschrift fuer Gerontologie und Geriatrie
Vol/bind50
Udgave nummer2
Sider (fra-til)115-122
ISSN0948-6704
DOI
StatusUdgivet - 2017

Citer dette

@article{57947a26f1c944dcb3c1db6f207c2ede,
title = "Benzodiazepine absetzen im Alter: Wann und, wenn ja, wie?",
abstract = "Although viewed critically in geriatrics, benzodiazepine use is still common among old people. Before reducing the dosage the following questions must be considered: 1. Are there indications for benzodiazepine treatment and will discontinuation cause relevant rebound symptoms of the initial disorder treated? 2. To what extent do the patient and other key persons consider discontinuation to be reasonable and will they support discontinuation? 3. Is the target complete withdrawal, a dose reduction or shift to another benzodiazepine drug which is more suitable in old age for pharmacokinetic reasons? This article provides assistance in answering these questions and some guidelines for the practical management of discontinuation. It is mandatory 1) to periodically address the problem of long-term benzodiazepine use when counseling the patient and key persons and 2) to be aware that several intermediate steps exist between continuation and complete discontinuation, which may be considered successful treatment.",
author = "Dirk Wolter",
year = "2017",
doi = "10.1007/s00391-016-1171-5",
language = "Tysk",
volume = "50",
pages = "115--122",
journal = "Zeitschrift fuer Gerontologie und Geriatrie",
issn = "0948-6704",
publisher = "Springer",
number = "2",

}

Benzodiazepine absetzen im Alter : Wann und, wenn ja, wie? / Wolter, Dirk.

I: Zeitschrift fuer Gerontologie und Geriatrie, Bind 50, Nr. 2 , 2017, s. 115-122.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Benzodiazepine absetzen im Alter

T2 - Wann und, wenn ja, wie?

AU - Wolter, Dirk

PY - 2017

Y1 - 2017

N2 - Although viewed critically in geriatrics, benzodiazepine use is still common among old people. Before reducing the dosage the following questions must be considered: 1. Are there indications for benzodiazepine treatment and will discontinuation cause relevant rebound symptoms of the initial disorder treated? 2. To what extent do the patient and other key persons consider discontinuation to be reasonable and will they support discontinuation? 3. Is the target complete withdrawal, a dose reduction or shift to another benzodiazepine drug which is more suitable in old age for pharmacokinetic reasons? This article provides assistance in answering these questions and some guidelines for the practical management of discontinuation. It is mandatory 1) to periodically address the problem of long-term benzodiazepine use when counseling the patient and key persons and 2) to be aware that several intermediate steps exist between continuation and complete discontinuation, which may be considered successful treatment.

AB - Although viewed critically in geriatrics, benzodiazepine use is still common among old people. Before reducing the dosage the following questions must be considered: 1. Are there indications for benzodiazepine treatment and will discontinuation cause relevant rebound symptoms of the initial disorder treated? 2. To what extent do the patient and other key persons consider discontinuation to be reasonable and will they support discontinuation? 3. Is the target complete withdrawal, a dose reduction or shift to another benzodiazepine drug which is more suitable in old age for pharmacokinetic reasons? This article provides assistance in answering these questions and some guidelines for the practical management of discontinuation. It is mandatory 1) to periodically address the problem of long-term benzodiazepine use when counseling the patient and key persons and 2) to be aware that several intermediate steps exist between continuation and complete discontinuation, which may be considered successful treatment.

U2 - 10.1007/s00391-016-1171-5

DO - 10.1007/s00391-016-1171-5

M3 - Tidsskriftartikel

VL - 50

SP - 115

EP - 122

JO - Zeitschrift fuer Gerontologie und Geriatrie

JF - Zeitschrift fuer Gerontologie und Geriatrie

SN - 0948-6704

IS - 2

ER -